GetTopicDetailResponse(id=5fd88902843, topicName=血小板反應(yīng)蛋白-1, introduction=血小板反應(yīng)蛋白-1, content=null, image=null, comments=2, allHits=1084, url=https://h5.medsci.cn/topic?id=89028, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=88542, tagList=[TagDto(tagId=88542, tagName=血小板反應(yīng)蛋白-1)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1974070, encodeId=e51919e4070c6, content=<a href='/topic/show?id=5fd88902843' target=_blank style='color:#2F92EE;'>#血小板反應(yīng)蛋白-1#</a>, objectTitle=Blood：血小板反應(yīng)蛋白-1通過(guò)調(diào)節(jié)血小板的cAMP信號(hào)促進(jìn)止血, objectType=article, longId=200715, objectId=4f0a200e151a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f0a200e151a, replyNumber=0, likeNumber=114, createdTime=2020-11-08, rootId=0, userName=haouestc, userId=7eeb2500172, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f0a200e151a, moduleTitle=Blood：血小板反應(yīng)蛋白-1通過(guò)調(diào)節(jié)血小板的cAMP信號(hào)促進(jìn)止血, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=4f0a200e151a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1974069, encodeId=54ff19e406909, content=<a href='/topic/show?id=5fd88902843' target=_blank style='color:#2F92EE;'>#血小板反應(yīng)蛋白-1#</a>, objectTitle=研究人員發(fā)現(xiàn)治療藥物性肝損傷的新靶標(biāo)：血小板反應(yīng)蛋白-1, objectType=article, longId=163895, objectId=0bde1638956a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0bde1638956a, replyNumber=0, likeNumber=83, createdTime=2020-03-19, rootId=0, userName=haouestc, userId=7eeb2500172, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0bde1638956a, moduleTitle=研究人員發(fā)現(xiàn)治療藥物性肝損傷的新靶標(biāo)：血小板反應(yīng)蛋白-1, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=0bde1638956a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
